Dyslipidemia usually refers to elevated serum levels of cholesterol (CH), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), and decreased levels of high-density lipoprotein cholesterol (HDL-C). Since lipids are present in plasma in the form of lipoproteins, dyslipidemia manifests as dyslipoproteinemia. Dyslipidemia can lead to atherosclerotic cardiovascular diseases (ASCVD) such as coronary heart disease, as well as increase the risk of tumors. Prevention and treatment of dyslipidemia is important to reduce the prevalence of cardiovascular disease and improve the quality of life. Patients with dyslipidemia are advised to seek medical treatment in time to avoid delays.